82 FR 14901 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 82, Issue 55 (March 23, 2017)

This publication corrects a notice that was published in the Federal Register on March 9, 2017 Volume 82, Number 45, page 13119. The meeting announcement and matters for discussion should read as follows: The meeting announced below concerns the Centers for Disease Control and Prevention (CDC) initial review of applications in response to Funding Opportunity Announcements (FOA) GH13-001, Strengthening Disease Prevention Research Capacity for Public Health Action in Guatemala and the Central American Region; FOA GH14-002, Addressing Emerging Infectious Diseases in Bangladesh; and FOA GH16-003, Conducting Public Health Research in Thailand: Technical collaboration with the Ministry of Public Health in the Kingdom of Thailand (MOPH). Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ``Strengthening Disease Prevention Research Capacity for Public Health Action in Guatemala and the Central American Region'', FOA GH13- 001; ``Addressing Emerging Infectious Diseases in Bangladesh'', FOA GH14-002; and ``Conducting Public Health Research in Thailand: Technical collaboration with the Ministry of Public Health in the Kingdom of Thailand (MOPH)'', FOA GH16-003.

[Federal Register Volume 82, Number 55 (Thursday, March 23, 2017)]
[Notices]
[Page 14901]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-05733]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns the Centers for Disease 
Control and Prevention (CDC) initial review of applications in response 
to Funding Opportunity Announcement (FOA) GH14-002, Addressing Emerging 
Infectious Diseases in Bangladesh; and FOA GH16-003, Conducting Public 
Health Research in Thailand: Technical collaboration with the Ministry 
of Public Health in the Kingdom of Thailand (MOPH).
SUMMARY: This publication corrects a notice that was published in the 
Federal Register on March 9, 2017 Volume 82, Number 45, page 13119. The 
meeting announcement and matters for discussion should read as follows:
    The meeting announced below concerns the Centers for Disease 
Control and Prevention (CDC) initial review of applications in response 
to Funding Opportunity Announcements (FOA) GH13-001, Strengthening 
Disease Prevention Research Capacity for Public Health Action in 
Guatemala and the Central American Region; FOA GH14-002, Addressing 
Emerging Infectious Diseases in Bangladesh; and FOA GH16-003, 
Conducting Public Health Research in Thailand: Technical collaboration 
with the Ministry of Public Health in the Kingdom of Thailand (MOPH).
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Strengthening Disease Prevention Research Capacity for Public 
Health Action in Guatemala and the Central American Region'', FOA GH13-
001; ``Addressing Emerging Infectious Diseases in Bangladesh'', FOA 
GH14-002; and ``Conducting Public Health Research in Thailand: 
Technical collaboration with the Ministry of Public Health in the 
Kingdom of Thailand (MOPH)'', FOA GH16-003.

FOR FURTHER INFORMATION CONTACT: Hylan Shoob, Scientific Review 
Officer, Center for Global Health (CGH) Science Office, CGH, CDC, 1600 
Clifton Road NE., Mailstop D-69, Atlanta, Georgia 30033, Telephone: 
(404) 639-4796, [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2017-05733 Filed 3-22-17; 8:45 am]
 BILLING CODE 4163-18-P